Abstract | OBJECTIVES: METHODS: A monocentric cohort of 87 adults with SLE (1960-1997) was studied to determine the risk factors for infection (disease activity evaluated by SLAM and SLEDAI scores, type of organ(s) involved or any biological abnormality, specific treatments) by comparing patients who had suffered at least one infectious episode (n=35; 40%) with non-infected patients (n=52; 60%). Prognostic indicators were assessed by comparing survivors at 10 years with non-survivors. RESULTS: CONCLUSION: In adults with SLE, infections are common and most often caused by community acquired bacteria. Intravenous corticosteroids and immunosuppressants are independent risk factors for infection, which is the only independent risk factor for death after 10 years of SLE evolution.
|
Authors | V Noël, O Lortholary, P Casassus, P Cohen, T Généreau, M H André, L Mouthon, L Guillevin |
Journal | Annals of the rheumatic diseases
(Ann Rheum Dis)
Vol. 60
Issue 12
Pg. 1141-4
(Dec 2001)
ISSN: 0003-4967 [Print] England |
PMID | 11709457
(Publication Type: Journal Article)
|
Chemical References |
- Glucocorticoids
- Immunosuppressive Agents
|
Topics |
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Analysis of Variance
- Bacterial Infections
(complications)
- Cohort Studies
- Female
- Glucocorticoids
(adverse effects, therapeutic use)
- Humans
- Immunocompromised Host
- Immunosuppressive Agents
(adverse effects, therapeutic use)
- Lupus Erythematosus, Systemic
(complications, drug therapy)
- Male
- Middle Aged
- Opportunistic Infections
(complications)
- Prognosis
- Retrospective Studies
- Risk Factors
- Survival Rate
|